
News
Press releases
April 26, 2022
Ambagon Therapeutics Appoints Gideon Bollag, Ph.D., to Scientific Advisory Board
January 6, 2022
Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
Media Contact
Rhiannon Jeselonis
rhiannon@tenbridgecommunications.com